Monoclonal antibody CanAg®for cancersCA 19-9
Add to favorites
Compare this product
Characteristics
- Type
- monoclonal antibody
- Applications
- for cancers
- Tested parameter
- CA 19-9
Description
The CanAg CA19-9 EIA is based on a mouse monoclonal antibody, C192, highly specific for the sialyl Lewisa epitope, also known as CA19-9 antigen1.
In adults, the epitope is typically expressed in trace amounts on mucosal cells of gastrointestinal epithelia. In patients with malignant disease, the epitope may appear associated with high molecular weight mucin in blood. Assays for CA19-9 are frequently used to monitor gastrointestinal malignancies such as pancreatic, gall bladder, gastric, and colorectal cancers
Exhibitions
Meet this supplier at the following exhibition(s):
LXXVI Reunión Anual de la SEN 2024
19-23 Nov 2024 Valencia (Spain)
Related Searches
- Fujirebio reagent
- Fujirebio test kit
- Fujirebio solution reagent
- Fujirebio blood test kit
- Fujirebio serum test kit
- Fujirebio immunoassay test kit
- Fujirebio plasma test kit
- Research reagent kit
- Fujirebio diagnostic reagent
- Protein reagent kit
- Fujirebio laboratory reagent
- Fujirebio infectious disease test kit
- Fujirebio molecular biology test kit
- Enzyme reagent kit
- Fujirebio respiratory disease test kit
- Whole blood detection kit
- Histology reagent kit
- Optical assay kit
- Fujirebio clinical test kit
- Cassette assay kit
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.